Several studies have also demonstrated an antiproliferative effect of progesterone in luminal breast cancer cells lines and patient-derived xenografts (PDXs) that have strong PR positivity, indicating that PR is more than a biomarker of breast cancer outcome. The gene discussed is PGR; the disease is breast cancer.